[Advance in immunotherapy on biliary tract cancers].

Area of Science:

• Oncology
• Immunology

Background:

• Biliary tract cancers (BTC), encompassing gallbladder cancer and cholangiocarcinoma, present significant clinical challenges.
• These cancers are characterized by low early diagnosis rates, complex anatomical locations, and resistance to conventional therapies like radiotherapy and chemotherapy, leading to poor prognoses.

Purpose of the Study:

• To review the emerging role of immunotherapy in the treatment of advanced biliary tract cancers.
• To highlight novel immunotherapeutic strategies being investigated for BTC.

Main Methods:

• Literature review of recent advancements in cancer immunotherapy.
• Focus on immune checkpoint inhibitors, adoptive immunotherapy, and tumor vaccines in the context of BTC.

Main Results:

• Immunotherapy has shown promise in treating various advanced solid tumors.
• Early applications of immunotherapy in BTC are demonstrating potential, with ongoing research into specific agents and modalities.

Conclusions:

• Immunotherapy represents a promising new frontier for managing biliary tract cancers.
• Further research and clinical trials are crucial to optimize the use of immunotherapy in BTC treatment protocols.